(Q44981563)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816805%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

title

Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816805%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816805%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

Chin-Hsiao Tseng

series ordinal

1

1 reference

7 December 2017

language of work or name

English

0 references

publication date

11 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816805%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

18 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816805%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

volume

145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816805%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816805%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

785-790

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816805%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-014-2985-8

18 March 2020

exact match

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2985-8

Clinical studies examining the impact of obesity on breast cancer risk and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2985-8

21 January 2018

Cancer trends in Taiwan.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2985-8

Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2985-8

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2985-8

Bias: considerations for research practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2985-8

Addressing different biases in analysing drug use on cancer risk in diabetes in non-clinical trial settings--what, why and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2985-8

Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2985-8

Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2985-8

Human insulin does not increase bladder cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2985-8

Pioglitazone does not affect the risk of ovarian cancer: analysis of a nationwide reimbursement database in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2985-8

New-onset diabetes with a history of dyslipidemia predicts pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2985-8

Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2985-8

The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2985-8

Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2985-8

Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2985-8

Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2985-8

Diabetes, cancer, and metformin: connections of metabolism and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2985-8

Molecular pathways: preclinical models and clinical trials with metformin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2985-8

10.1007/S10549-014-2985-8

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816805%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference